Gene Salkind - 15 Sep 2025 Form 4 Insider Report for Mobiquity Technologies, Inc. (MOBQ)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: MOBQ
Reported as of: 15 Sep 2025
Net transaction value: +$25,000
SEC form: 4
Accepted by SEC: 19 Sep 2025, 17:00:05 UTC
Prior SEC filing: 30 Jul 2025
Next SEC filing: 18 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Gene Salkind

Key filing fact

Gene Salkind filed Form 4 for Mobiquity Technologies, Inc. (MOBQ) on 19 Sep 2025.

Key facts

This page summarizes Gene Salkind's Form 4 filing for Mobiquity Technologies, Inc. (MOBQ).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 19 Sep 2025, 17:00.

Change

Previous filing in this sequence was filed on 30 Jul 2025.
Current net transaction value: +$25,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001592481 Primary reporting owner

Salkind Gene

Relationship: Director, 10%+ Owner
Address: 35 TORRINGTON LANE, SHOREHAM
Signature: /s/ Gene Salkind
Signature date: 17 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MOBQ transaction

Common Stock

Award

Transaction value: $25,000
Shares: +25,000
Change %: +0.29%
Price: $1.00
Shares after: 8,668,695
Date: 15 Sep 2025
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MOBQ transaction Derivative

Convertible notes

Award

Transaction value
Shares: +100,000
Change %: +24%
Price
Shares after: 511,544
Date: 15 Sep 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 100,000
Exercise price: $1.00
Footnotes: F2, F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents interest paid on a convertible note

Footnote F2

The securities listed in Table I and Table II are securities owned directly by Dr. Salkind and his wife and by a family trust.

Footnote F3

Not applicable.

Footnote F4

Includes (i) 59,211 shares underlying warrants exercisable at $60 per share, (ii) 2,333 shares underlying options exercisable at $68.48 per share, (iii) 100,000 shares underlying options exercisable at $.20 per share, (iv)100,000 shares underlying a convertible note at $1.00 per share and (v) options to purchase 250,000 shares exercisable at $2.45 per share.